At the forefront of medical technology

The WATCHMAN device used at The Valley Hospital acts as a filter to close the opening to the left atrial appendage (LAA) of the heart. It prevents blood clots that form in the LAA from breaking off and going to the brain.

High technology

New Jersey hospitals use the latest medical device technology to treat patients.

Medical technology has changed the face of healthcare. From wearable heart devices for surgical robots, the new technology has helped doctors reduce morbidity and mortality, as well as improve the quality of life of patients.

Here’s a look at three health care systems in New Jersey that have successfully implemented state-of-the-art medicinel technology.

In 2021, the global market for surgical robots was valued at $ 3.6 billion. According to the San Francisco-based Grandview Research, it is expected to expand at an annual growth rate of 19.3% from 2022 to 2030. The shortage of doctors and surgeons and the growing adoption of automated tools used for operations are among the main drivers of the market.

At St. Peter’s University Hospital in New Brunswick, the robotic program has gained popularity over the past decade.

“Our robots are usIt is in the top 90 percent of the rest of the country, ”said David A. Laskou, Ph.D., chairman, Department of Surgery.

Laskou adds that almost all general surgeons have significant experience in using the DaVinci robot, which is currently being used.ed for liver resection, distal pancreatomy and robotic splenectomy, as well as all gastric sleeves for bariatric surgery.

One of the biggest costs for the hospital is the length of stay, according to Laskow.

“Because we are able to do these robotic procedures so that effthe effective and efficient length of stay between an open case (traditional surgery) and robotic surgery is drastically different. As the length of stay decreases, you will reimburse the costs, ”says Laskow.

New technologies are also being used in St. Peter to help doctors fight sleep apnea and intestinal and urinary incontinence.

Medtronic’s InterStim technology delivers electrical stimulation to the sacral nerves in the pelvic area, restores brain-gut communication and ultimately reduces symptomsoms.

As an alternative to the traditional CPAP (continuous positive airway pressure therapy) for patients with sleep apnea, doctors from St. Peter’s has deployed an implantable upper airway stimulator from Inspire Medical Systems, Inc. The device isstabilizes the patient’s airway while sleeping to prevent obstruction.

According to the Centers for Disease Control and Prevention, lung cancer is the leading cause of death from cancer and the second most diagnosed cancer in men and women in the United States.

Traditionally, patients with lung spots have had to go through a procedure called a needle biopsy, in which a radiologist inserts a needle through the chest wall and into the lungs to obtain a tissue sample for biopsy.

Charles Shea, MD, chest jumpand medical director of lung cancer at Inspira Health, says many of the spots are in places that are not subject to needle biopsy.

At Inspira Health, doctors use the Redwood City-based Monarch bronchoscopy platform, Auris Health, Inc., since 2021

Shieh says robotic navigational bronchoscopy allows doctors to get a biopsy from the inside out through the airways, not from the outside in through the skin.

“He looks down the airway or the airway and into the smaller ones respiratory tract. Traditional bronchoscopy is not guided, which means that the doctor does not know where it is in the lungs. However, with navigational bronchoscopy using the Monarch platform, when you do the procedure, you know exactly where you are in the chest.

In addition, Shieh says the technology allows the surgeon to both diagnose and then follow any necessary treatment, such as resection (surgical removal).

“You can think of this technology as a one-stop shop. If the patient comes with a lung cancer, I will be able to diagnose the patient as well as treat the patient, “he said.

Another advantage, Shea says, is that patients do not have to go to a huge medical center to take advantage of the technology: “They can come to their local hospital here in South Jersey in Inspira and we are able to perform all these functions that previously could only be performed by large centers.

Cardiologists at The Valley Hospital in Ridgewood have a new tool in their arsenal for the treatment of atrial fibrillation (Afib), one ofost common heart disease.

“There is great interest in identifying high-risk patients with Afib and providing them with treatment options that will reduce their likelihood of stroke,” said Sunit Mittal, Ph.D., director, electrophysiologist and associate. Chief Medical Officer of Cardiology, Snyder AF Center, Director, Cardiac Research at The Valley Hospital.

Mittal points out that while blood thinners are commonly used to prevent the formation of blood clots in the heart, they can cause bleeding when used. for a long time.

He added that one of the biggest reasons people get strokes with Afib is that they develop a blood clot in their heart that can break off and enter the brain and stay there and cause a stroke.

As an alternative to blood diluents for patients with Afib who are at high risk of bleeding, Mittal and his colleagues turned to the WATCHMAN from Boston Scientific and the Amplatzer Amulet from Abbott.

“Watchman and Amulet work on the principle essentially a filter to seal the opening to the left atrial appendage (LAA), ”says Mittal. “These devices prevent blood clots that form in the LAA from breaking away and going to the brain and causing a stroke.

Mittal says studies show that if these devices can be successfully implanted in patients, then the risk of stroke is much lower than would be expected if they were not on a blood thinner.

Implantable devices usually include a preliminary price compared to blood thinnerse has a daily price for a long period of time, according to Mittal.

“The biggest price is the risk of morbidity. Leaving someone with a stroke disability can cause a lot of direct and indirect costs to our society. “

Mittal says he is impoPatients who have Afib should be educated that they have options when it comes to treatment.

“Blood thinners will work the vast majority of patients. For those who have challenges with blood thinner, they need to know that there are more options.

To access more business news, visit NJB news now.

Related articles:

Leave a Comment

Your email address will not be published.